macular degeneration glp 1 A Critical Eye on GLP-1 Receptor Agonists GLP-1s were huge in 2025,

And theres more: Chronic administration of methyl B12 was shown to protect cultured retinal neurons against N-methyl-D-aspartate-receptor-mediated glutamate neurotoxicity

Learn about our services and specialties

New opportunities lie in: Expansion into emerging markets with tailored GLP-1 therapies Development of combination therapies to enhance efficacy Investment in digital health platforms for patient engagement By 2035, the GLP-1 Drug Market is expected to achieve substantial growth and innovation

Competitive Landscape The global glutathione market exhibits a moderately consolidated competitive structure, with leading manufacturers including Kyowa Hakko Bio Co., Ltd., Ajinomoto Co., Inc., and Shandong Jincheng Biological Pharmaceutical Co., Ltd

10.1002/biof.1932 42 HosseiniH.BagherniyaM.SahebkarA.IrajB.MajeedM.AskariG